ABL Bio

AbCellera Biologics

The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.

ybiologics

The company develops antibody-based therapeutics and immuno-oncology drugs for pharmaceutical partners and the global healthcare sector.

Abalone Bio

This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.

Zymeworks

The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.

Ablynx NV

This company develops nanobody-based therapeutic proteins to treat inflammation, haematology, oncology and pulmonary diseases for pharmaceutical partners and patients.

Pinot Bio

The company develops antibody-drug conjugate platforms and targeted anticancer therapeutics for pharmaceutical firms and clinical-stage biotechnology partners.

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

AbCellera

This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.